Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | March 12, 2024 01:31pm

Gainers

  • Regulus Therapeutics (NASDAQ:RGLS) stock increased by 94.9% to $2.69 during Tuesday's regular session. The company's market cap stands at $54.3 million.
  • Bright Green (NASDAQ:BGXX) shares increased by 66.42% to $0.35. The market value of their outstanding shares is at $63.9 million.
  • SCWorx (NASDAQ:WORX) stock increased by 29.33% to $2.42. The company's market cap stands at $2.9 million.
  • Assure Hldgs (NASDAQ:IONM) stock moved upwards by 21.55% to $0.41. The market value of their outstanding shares is at $2.7 million.
  • TRACON Pharma (NASDAQ:TCON) stock increased by 18.89% to $0.34. The market value of their outstanding shares is at $15.6 million.
  • Viracta Therapeutics (NASDAQ:VIRX) stock increased by 17.96% to $1.05. The market value of their outstanding shares is at $41.2 million. The company's, Q4 earnings came out 3 days ago.

Losers

  • Lexaria Bioscience (NASDAQ:LEXX) stock declined by 30.5% to $4.34 during Tuesday's regular session. The company's market cap stands at $53.7 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 28.56% to $0.48. The market value of their outstanding shares is at $43.8 million.
  • Psyence Biomedical (NASDAQ:PBM) stock declined by 24.86% to $1.33. The company's market cap stands at $17.8 million.
  • Caribou Biosciences (NASDAQ:CRBU) shares decreased by 24.38% to $5.46. The market value of their outstanding shares is at $482.8 million. As per the news, the Q4 earnings report came out yesterday.
  • Renalytix (NASDAQ:RNLX) stock fell 23.4% to $0.87. The company's market cap stands at $43.6 million.
  • NKGen Biotech (NASDAQ:NKGN) stock declined by 20.31% to $2.04. The market value of their outstanding shares is at $44.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BGXX CRBU IONM LEXX NKGN NRXP PBM RGLS RNLX TCON VIRX WORX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist